Significant further evidence to bolster the link between epoetin and strokes in chronic kidney disease and cancer |
| |
Authors: | Goldsmith David J Covic Adrian C |
| |
Affiliation: | Renal and Transplantation Unit, Guy's Hospital, King's Health Partners AHSC, London, UK. david.goldsmith@gstt.nhs.uk |
| |
Abstract: | Erythropoiesis-stimulating agents (ESAs) have been used for about three decades in chronic kidney disease patients to treat the symptoms of anemia, avoid potentially hazardous blood-product transfusions, improve some facets of quality of life, and reduce cardiovascular risk. We review a new article in which this association between stroke and ESA use is examined in a different population in a different way, but with the same worrying findings as seen in the TREAT study. |
| |
Keywords: | |
本文献已被 PubMed 等数据库收录! |
|